Dyno Therapeutics
Biotechnology ResearchMassachusetts, United States51-200 Employees
Building high-performance genetic technologies that transform patient lives.
Strategic Partnerships Dyno Therapeutics has established strategic partnerships with industry leaders like NVIDIA, Sarepta, Novartis, and Roche. Leveraging these collaborations can open doors to potential sales opportunities through joint projects or technology licensing.
Product Launches The recent launches of Dyno eCap 1 capsid product and Optimized AAV Capsids for eye and CNS Gene Delivery showcase the company's innovation in gene therapy solutions. Positioning these cutting-edge products to address unmet medical needs can attract sales interest from healthcare providers and research institutions.
Industry Recognition Dyno Therapeutics' recognition as the Emerging Company of the Year at the NEVY Awards signifies its industry impact and growth potential. This accolade can serve as a powerful sales tool to build credibility and trust among potential clients and investors.
Advanced Technology Utilizing next-gen DNA technologies, machine learning, and AI-powered drug design platforms, Dyno Therapeutics is at the forefront of innovation in biotechnology research. Highlighting the company's technological prowess can attract sales opportunities from organizations seeking cutting-edge solutions.
Market Expansion With a revenue range of $10M - 50M and recent expansions into international markets, Dyno Therapeutics demonstrates financial stability and growth potential. Expanding the company's market presence can unlock sales opportunities in new geographic regions and diverse customer segments.
Dyno Therapeutics uses 8 technology products and services including Google Analytics, LinkedIn Recruiter, jsDelivr, and more. Explore Dyno Therapeutics's tech stack below.
Dyno Therapeutics Email Formats | Percentage |
First.Last@dynotx.com | 98% |
FL@dynotx.com | 1% |
First@dynotx.com | 1% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
Building high-performance genetic technologies that transform patient lives.
Dyno Therapeutics has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 06, 2021 in the amount of $100M.
Dyno Therapeutics's revenue is in the range of $10M$50M
Dyno Therapeutics has raised a total of $100M of funding over 3 rounds. Their latest funding round was raised on May 06, 2021 in the amount of $100M.
Dyno Therapeutics's revenue is in the range of $10M$50M